Related Experiment Video
Updated: Aug 8, 2026

Ex Vivo Optogenetic Dissection of Fear Circuits in Brain Slices
Published on: April 6, 2016
Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the
1Department of Neuropharmacology, Scripps Research Institute, La Jolla, California, USA.
Insights
Interferon-alpha stimulates stress-related factor release from the amygdala and hypothalamus. Transforming growth factor-beta 1 selectively blocks acetylcholine-induced release, suggesting a role in modulating the neuroendocrine-immune axis.
Area of Science:
- Neuroendocrinology
- Neuroimmunology
- Molecular Psychiatry
Background:
- Interferon-alpha (IFN-alpha) and transforming growth factor-beta 1 (TGF-beta 1) are cytokines found in brain regions.
- The amygdala, rich in corticotropin-releasing factor (CRF), is central to stress responses.
- IFN-alpha releases arginine vasopressin (AVP) from the amygdala and hypothalamus, indicating neuroimmune roles.
Purpose of the Study:
- To compare the effects of IFN-alpha and TGF-beta 1 on in vitro CRF release from the amygdala and hypothalamus.
- To investigate the involvement of guanylate cyclase-mediated signaling in cytokine-induced CRF release.
Main Methods:
- In vitro study of CRF release from rat amygdala and hypothalamus.
- Treatment with IFN-alpha, TGF-beta 1, Interleukin-2 (IL-2), and acetylcholine.
- Assessment of guanylate cyclase inhibitors and cGMP accumulation.
Main Results:
- IFN-alpha stimulated CRF release from both amygdala and hypothalamus.
- CRF release induced by IFN-alpha, IL-2, and acetylcholine was blocked by guanylate cyclase inhibitors.
- TGF-beta 1 did not affect basal or IL-2-induced CRF release but blocked acetylcholine-induced CRF release.
Conclusions:
- IFN-alpha promotes CRF release via guanylate cyclase-mediated signaling.
- TGF-beta 1 antagonizes acetylcholine-evoked CRF and AVP release, potentially modulating HPA axis activation.
- The amygdala plays a key role in bidirectional communication within the neuroendocrine-immune system.
Abstract:
Interferon-alpha (IFN-alpha) and transforming growth factor-beta 1 (TGF-beta 1) have been reported in different brain regions. The amygdala contains high levels of corticotropin releasing factor (CRF) and has been implicated as a central site for its stress-related autonomic and behavioral response. IFN-alpha will release arginine vasopressin (AVP) from both amygdala and hypothalamus, which further supports a role for the amygdala in neuroimmune interactions. In the present study, we compared the effects of these cytokines on the in vitro release of CRF from the amygdala and hypothalamus. In addition, we evaluated the possible involvement of guanylate cyclase-mediated signaling in CRF release. IFN-alpha stimulates CRF release from both amygdala and hypothalamus. The CRF release by IFN-alpha, Interleukin-2 (IL-2) and acetylcholine is blocked by guanylate cyclase inhibitors, indicating a role for cGMP accumulation in this CRF release. TGF-beta 1 had no effect on basal release of CRF, nor on the CRF-release induced by IL-2, but selectively blocked the acetylcholine-induced release in both amygdala and hypothalamus. Taken with a previous report that TGF-beta 1 specifically inhibits AVP release by acetylcholine, these results suggest that TGF-beta 1 may modulate HPA axis activation, by antagonizing (acetylcholine-evoked) CRF and AVP release. These data further support a role for the amygdala in the bidirectional communication between neuroendocrine and immune system.
More Related Videos
Related Concept Videos
Feedback Loops
Hypothalamic-Pituitary Axis
TGF - β Signaling Pathway
Regulation of Hormone Secretion
Humoral stimuli,...
Regulation of Food Intake
Cushing Syndrome II: Pathophysiology

